CHRO P/E Ratio
P/E Ratio as of Jul 3, 2025: -0.94
Average-0.7276
Median-0.7000
Minimum-0.9500
Maximum-0.6200
-0.94
Past Month-0.34 (56.67%)
The P/E ratio for CHRO is -0.94 as of Jul 3, 2025. This represents a increase of 40.30% compared to its 12-month average P/E ratio of -0.67. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Chromocell Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Chromocell Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Chromocell Therapeutics Corp to industry peers.
Chromocell Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Chromocell Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Chromocell Therapeutics Corp to industry peers.
CHRO P/E Ratio Insights
See Chromocell Therapeutics Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CHRO
Order type
Buy in
Order amount
Est. shares
0 shares
CHRO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $13.50 | -0.78 |
| Jun 2, 2025 | $10.20 | -0.59 |
| May 1, 2025 | $12.50 | -0.72 |
| Apr 1, 2025 | $13.50 | -0.78 |
| Mar 3, 2025 | $22.00 | -1.27 |
| Feb 3, 2025 | $21.30 | -1.23 |
| Jan 2, 2025 | $7.2338 | -0.42 |
CHRO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.94 | +154.05% |
| 2024 | -0.37 | — |
FAQs About Chromocell Therapeutics Corp (CHRO) P/E ratio
The latest P/E ratio of CHRO is -0.94, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Chromocell Therapeutics Corp’s last 12-month average P/E ratio is -0.67, compared to its current P/E ratio of -0.94. This reflects a increase of 40.30%.
Chromocell Therapeutics Corp’s current P/E ratio of -0.94 is higher than its last 12-month average P/E of -0.67. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Chromocell Therapeutics Corp’s average P/E ratio over the last 3 years is -0.53. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Chromocell Therapeutics Corp’s average P/E ratio over the last 5 years is -0.32. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.